Virax Biolabs Group Ltd Comprehensive Income Attributable To Noncontrolling Interests
Virax Biolabs Group Ltd (VRAX) reported Comprehensive Income Attributable To Noncontrolling Interests of -$5.99 thousand for the 12-month period ending 2025-03-31, per its 20-F filed 2025-07-02.
Financial Statements › Income Statement › Unrealized Gains
ifrs-full:ComprehensiveIncomeAttributableToNoncontrollingInterests · last filed 2025-07-02
| Period end | Comprehensive Income Attributable To Noncontrolling Interests 12 month |
|---|---|
| 2025-03-31 | -$5.99K 20-F · filed 2025-07-02 |
| 2024-03-31 | -$5.58K 20-F · filed 2025-07-02 |
| 2023-03-31 | -$269.00 20-F · filed 2025-07-02 |
| 2022-03-31 | -$78.06K 20-F · filed 2024-08-20 |
| 2021-03-31 | -$30.20K 20-F · filed 2022-08-12 |